UW SPH’s Connie Celum receives the 2024 ASPPH Research Excellence Award

UW School of Public Health

Dr. Connie Celum, professor at the University of Washington Schools of Public Health and Medicine, is the recipient of the Association of Schools and Programs of Public Health’s (ASPPH) 2024 Research Excellence Award. ASPPH awards honor individuals who exhibit excellence in education, research, practice, student services, and exceptional community engagement. The awardees will be recognized at the Annual ASPPH Meeting Awards Luncheon on March 21 in Arlington, VA.

Community care model improves uptake of TB preventive therapy, KZN study finds

Spotlight

The uptake and continuation of tuberculosis (TB) preventive therapy were much higher when it was provided through a community-based model compared to the standard clinic-based model, a study conducted in KwaZulu-Natal found. The findings were presented at the recent Conference for Retroviruses and Opportunistic Infections in Seattle, USA.

DGH faculty members Adrienne Shapiro, Ruanne Barnabas (now at Massachusetts General Hospital), and Connie Celum were involved in the research, as well as DGH staff members Torin Schaafsma, Meighan Krows, and Susan Morrison.

DoxyPEP is a morning-after pill to prevent sexually transmitted infections

Vox

Years after it was first proven to work, a new tool for preventing sexually transmitted infections is on the brink of entering mainstream medicine. That tool is doxyPEP, an antibiotic that works like a morning-after pill — but instead of preventing pregnancy within hours of unprotected sex, it prevents STIs like chlamydia and syphilis.

Dr. Connie Celum, professor of global health and of medicine at the UW, is referenced.

Widely available antibiotic helps prevent bacterial STIs in certain populations, UW clinical trial finds

The Seattle Times

New research has found an antibiotic that’s been around for decades could help prevent sexually transmitted bacterial diseases, according to a recent University of Washington clinical trial that proved so effective in certain populations it ended early.

Dr. Connie Celum, a UW professor of global health, medicine and epidemiology co-led the research.

Pages